Riluzole Tablet, Film Coated
Product Images NDC 68462-381

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 68462-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a graph that depicts the Kaplan-Meier Survival Curves for Riluzole 50 mg administered twice daily and Placebo. It shows the survival probability rates at different time intervals. The survival probability rates range from 1.0 to 0.1. The number of individuals in each group is mentioned in parentheses beside the group name.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
The text describes a figure titled "Kaplan-Meier Survival Curves", presenting survival probability data for Riluzole 50 mg Twice Daily (N=236) and Placebo (N=242).*
FDA Label Image
Glenmark Logo
This text is not useful as it only contains one letter and a company name, "glenmark".*
FDA Label Image

Label 50mg

Label 50mg
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.